Quick Answer
Crinetics Pharmaceuticals, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $7.70 million for the year ending 2025.
- Crinetics Pharmaceuticals, Inc. showed an increase of +640.7% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Crinetics Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Crinetics Pharmaceuticals, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 1,206.6%.
- Historical annual values: Fiscal year 2025: $7.70 million | Fiscal year 2024: $1.04 million | Fiscal year 2023: $4.01 million | Fiscal year 2022: $0.00 | Fiscal year 2021: $0.00 | Fiscal year 2020: $71.0 thousand | Fiscal year 2019: $1.19 million | Fiscal year 2018: $2.43 million | Fiscal year 2017: $2.05 million | Fiscal year 2016: $589.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: